Table 5 Relationship between CA19-9 and POPF by operative method
| Ā | CA19-9 (U/mL) | CA19-9ā<ā428 (nā=ā123) | CA19-9āā„ā428 (nā=ā57) |
|---|---|---|---|
PD (nā=ā122) | Ā | 83 | 39 |
Ā Non-PF (nā=ā99) | 1109āĀ±ā523 | 74 (89.2%) | 25 (64.1%) |
Ā PF (nā=ā23) | 1808āĀ±ā917 | 9 (10.8%) | 14 (35.9%) |
Ā P-value | Pā=ā0.024 | Pā=ā0.0014 | |
DP (nā=ā58) | Ā | 40 | 18 |
Ā Non-PF (nā=ā40) | 469āĀ±ā255 | 33 (82.5%) | 7 (38.9%) |
Ā PF (nā=ā18) | 1199āĀ±ā503 | 7 (17.5%) | 11 (61.1%) |
Ā P-value | Pā=ā0.054 | Pā=ā0.0011 | |